Bolt Biotherapeutics (BOLT) Stock Forecast, Price Target & Predictions
BOLT Stock Forecast
Bolt Biotherapeutics stock forecast is as follows: an average price target of $1.00 (represents a 75.44% upside from BOLT’s last price of $0.57) and a rating consensus of 'Hold', based on 13 wall street analysts offering a 1-year stock forecast.
BOLT Price Target
BOLT Analyst Ratings
Hold
Bolt Biotherapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 15, 2024 | Daina Graybosch | Leerink Partners | $1.00 | $1.32 | -24.24% | 75.44% |
10
Bolt Biotherapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $1.00 |
Last Closing Price | $0.57 | $0.57 | $0.57 |
Upside/Downside | -100.00% | -100.00% | 75.44% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 15, 2024 | H.C. Wainwright | - | Neutral | Downgrade |
May 15, 2024 | Leerink Partners | - | Market Perform | Downgrade |
May 14, 2024 | Guggenheim | - | Neutral | Downgrade |
May 12, 2023 | Credit Suisse | - | Outperform | Upgrade |
May 12, 2023 | Raymond James | - | Market Perform | Upgrade |
May 12, 2023 | Cantor Fitzgerald | - | Overweight | Upgrade |
May 12, 2023 | Exane BNP Paribas | - | Neutral | Downgrade |
May 12, 2023 | Wells Fargo | - | Underweight | Downgrade |
May 12, 2023 | Barclays | - | Equal-Weight | Downgrade |
May 12, 2023 | BMO Capital | - | Market Perform | Downgrade |
10
Bolt Biotherapeutics Financial Forecast
Bolt Biotherapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $2.09M | $2.53M | $1.43M | $1.83M | $1.41M | $2.11M | $1.39M | $813.00K | $508.00K | $752.00K | - | - |
Avg Forecast | $200.00K | $200.00K | $300.00K | $400.00K | $1.07M | $1.25M | $1.01M | $2.08M | $1.71M | $1.73M | $1.91M | $1.54M | $1.24M | $990.00K | $500.00K | $500.00K | $375.00K | $375.00K | $3.33M | $33.33K |
High Forecast | $236.81K | $236.81K | $355.21K | $473.62K | $1.33M | $1.28M | $1.03M | $2.08M | $2.16M | $2.04M | $2.26M | $1.82M | $1.46M | $990.00K | $500.00K | $500.00K | $375.00K | $375.00K | $3.33M | $33.33K |
Low Forecast | $146.69K | $146.69K | $220.03K | $293.38K | $565.79K | $1.23M | $977.70K | $2.07M | $1.30M | $1.27M | $1.40M | $1.13M | $905.80K | $990.00K | $500.00K | $500.00K | $375.00K | $375.00K | $3.33M | $33.33K |
# Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Surprise % | - | - | - | - | - | - | - | - | 1.22% | 1.46% | 0.75% | 1.19% | 1.14% | 2.13% | 2.79% | 1.63% | 1.35% | 2.01% | - | - |
Forecast
Bolt Biotherapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
EBITDA | - | - | - | - | - | - | - | - | $-19.77M | $-18.18M | $-19.83M | $-17.95M | $-21.04M | $-21.91M | $-22.65M | $-23.52M | $-26.80M | $-23.09M | $-23.33M | $-30.81M |
Avg Forecast | $-200.00K | $-200.00K | $-300.00K | $-400.00K | $-1.07M | $-1.25M | $-1.01M | $-2.08M | $-1.71M | $-1.73M | $-1.91M | $-1.54M | $-1.24M | $-990.00K | $-500.00K | $-500.00K | $-375.00K | $-375.00K | $-47.01M | $-33.33K |
High Forecast | $-146.69K | $-146.69K | $-220.03K | $-293.38K | $-565.79K | $-1.23M | $-977.70K | $-2.07M | $-1.30M | $-1.27M | $-1.40M | $-1.13M | $-905.80K | $-990.00K | $-500.00K | $-500.00K | $-375.00K | $-375.00K | $-37.61M | $-33.33K |
Low Forecast | $-236.81K | $-236.81K | $-355.21K | $-473.62K | $-1.33M | $-1.28M | $-1.03M | $-2.08M | $-2.16M | $-2.04M | $-2.26M | $-1.82M | $-1.46M | $-990.00K | $-500.00K | $-500.00K | $-375.00K | $-375.00K | $-56.41M | $-33.33K |
Surprise % | - | - | - | - | - | - | - | - | 11.54% | 10.53% | 10.38% | 11.65% | 17.04% | 22.13% | 45.30% | 47.04% | 71.46% | 61.58% | 0.50% | 924.43% |
Forecast
Bolt Biotherapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Net Income | - | - | - | - | - | - | - | - | $-17.90M | $-16.26M | $-18.06M | $-15.54M | $-18.95M | $-21.17M | $-22.27M | $-23.48M | $-27.16M | $-23.39M | $-23.59M | $-31.04M |
Avg Forecast | $-8.03M | $-15.68M | $-15.68M | $-15.68M | $-13.87M | $-13.01M | $-16.75M | $-19.51M | $-17.98M | $-19.13M | $-18.23M | $-19.13M | $-22.44M | $-21.10M | $-25.07M | $-26.79M | $-30.81M | $-28.60M | $-47.17M | $-24.53M |
High Forecast | $-5.25M | $-10.25M | $-10.25M | $-10.25M | $-10.92M | $-8.50M | $-10.95M | $-12.75M | $-15.30M | $-12.50M | $-11.91M | $-12.50M | $-14.66M | $-21.10M | $-25.07M | $-26.79M | $-30.81M | $-28.60M | $-37.74M | $-24.53M |
Low Forecast | $-9.95M | $-19.44M | $-19.44M | $-19.44M | $-16.39M | $-16.12M | $-20.76M | $-24.18M | $-19.89M | $-23.70M | $-22.60M | $-23.70M | $-27.81M | $-21.10M | $-25.07M | $-26.79M | $-30.81M | $-28.60M | $-56.60M | $-24.53M |
Surprise % | - | - | - | - | - | - | - | - | 1.00% | 0.85% | 0.99% | 0.81% | 0.84% | 1.00% | 0.89% | 0.88% | 0.88% | 0.82% | 0.50% | 1.27% |
Forecast
Bolt Biotherapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
SG&A | - | - | - | - | - | - | - | - | $5.53M | $5.76M | $5.62M | $5.62M | $5.61M | $5.49M | $5.53M | $6.30M | $5.10M | $4.94M | $4.05M | $2.06M |
Avg Forecast | $3.39M | $3.39M | $5.09M | $6.78M | $18.22M | $21.20M | $17.04M | $35.18M | $29.04M | $29.26M | $32.39M | $26.11M | $20.94M | $16.78M | $8.48M | $8.48M | $6.36M | $6.36M | $56.51M | $565.10K |
High Forecast | $4.01M | $4.01M | $6.02M | $8.03M | $22.54M | $21.62M | $17.51M | $35.18M | $36.55M | $34.65M | $38.35M | $30.91M | $24.79M | $16.78M | $8.48M | $8.48M | $6.36M | $6.36M | $56.51M | $565.10K |
Low Forecast | $2.49M | $2.49M | $3.73M | $4.97M | $9.59M | $20.78M | $16.58M | $35.18M | $22.11M | $21.46M | $23.76M | $19.15M | $15.36M | $16.78M | $8.48M | $8.48M | $6.36M | $6.36M | $56.51M | $565.10K |
Surprise % | - | - | - | - | - | - | - | - | 0.19% | 0.20% | 0.17% | 0.22% | 0.27% | 0.33% | 0.65% | 0.74% | 0.80% | 0.78% | 0.07% | 3.64% |
Forecast
Bolt Biotherapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.00 | $-0.48 | $-0.41 | $-0.50 | $-0.57 | $-0.60 | $-0.63 | $-0.73 | $-0.63 | $-0.64 | $-0.97 |
Avg Forecast | $-0.21 | $-0.41 | $-0.41 | $-0.41 | $-0.36 | $-0.34 | $-0.44 | $-0.51 | $-0.47 | $-0.50 | $-0.48 | $-0.50 | $-0.59 | $-0.55 | $-0.66 | $-0.70 | $-0.81 | $-0.75 | $-0.58 | $-0.64 |
High Forecast | $-0.14 | $-0.27 | $-0.27 | $-0.27 | $-0.29 | $-0.22 | $-0.29 | $-0.33 | $-0.40 | $-0.33 | $-0.31 | $-0.33 | $-0.38 | $-0.55 | $-0.66 | $-0.70 | $-0.81 | $-0.75 | $-0.58 | $-0.64 |
Low Forecast | $-0.26 | $-0.51 | $-0.51 | $-0.51 | $-0.43 | $-0.42 | $-0.54 | $-0.63 | $-0.52 | $-0.62 | $-0.59 | $-0.62 | $-0.73 | $-0.55 | $-0.66 | $-0.70 | $-0.81 | $-0.75 | $-0.58 | $-0.64 |
Surprise % | - | - | - | - | - | - | - | - | 0.00% | 0.00% | 1.01% | 0.82% | 0.85% | 1.03% | 0.91% | 0.90% | 0.90% | 0.84% | 1.09% | 1.51% |
Forecast
Bolt Biotherapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SPRO | Spero Therapeutics | $1.20 | $10.00 | 733.33% | Buy |
CTMX | CytomX Therapeutics | $0.87 | $5.73 | 558.62% | Buy |
TIL | Instil Bio | $23.36 | $78.25 | 234.97% | Hold |
NUVB | Nuvation Bio | $2.58 | $6.75 | 161.63% | Buy |
ASMB | Assembly Biosciences | $15.02 | $35.50 | 136.35% | Buy |
NXTC | NextCure | $1.30 | $3.00 | 130.77% | Buy |
ACHL | Achilles Therapeutics | $1.07 | $2.00 | 86.92% | Buy |
BOLT | Bolt Biotherapeutics | $0.57 | $1.00 | 75.44% | Hold |